These are all the areas and issues on which the Malta Federation of Industry was asked to forward its feedback during the past two weeks:
Provisions and possible EU restrictions of Perfluoro Octane Sulphonates (PFOS);
Proposed amendments to the Medical Devices Directive; and
Defining the impact of EU membership on Malta's pharmaceutical sector. As the respective consultation processes often have deadlines for the submission of feedback, any FOI member wishing to have more information or wishing to incorporate the company's comments in the FOI position on these issues, is to contact the FOI Secretariat as soon as possible on tel: 2122-2074 or 2123-4428.